Recent research demonstrate the promise of RMP1-14, a recently engineered anti-mouse PD-1 therapeutic, for boosting cancer immunotherapy . Unlike existing approaches, RMP1-14 exhibits enhanced binding https://socialrus.com/story24433747/harnessing-rmp1-14-a-innovative-anti-mouse-pd-1-agent-in-immunotherapy